Monday 30 December 2024

The Pharma Letter Podcast — Episode 27 — How to develop cancer drugs faster, with Ellipses Pharma

Biotechnology
Simon Wentworth
23 January 2024
episode-27-big

More on this story...

Pharmaceutical
The trust complex - strengthening the fundamentals of communications is more important than ever
8 February 2024
Pharmaceutical
Growing J&J sales tempered by rising costs
23 January 2024
Pharmaceutical
Doubling down on deep customer insights to inform value demonstration
5 February 2024
Pharmaceutical
BRIEF—Trends shaping healthcare marketplace analyzed in report
2 February 2024


Companies featured in this story

More ones to watch >


Today's issue

UK regulator warns against illegal weight loss meds
Pharmaceutical
UK regulator warns against illegal weight loss meds
30 December 2024
Pharmaceutical
2024: Emergent trends in pharma and biotech
30 December 2024
Pharmaceutical
Zorifer poised to fill critical gap for advanced NSCLC with CNS metastases in China, says analyst
30 December 2024
Biotechnology
Rybrevant combo gains EU nod in first-line lung cancer
30 December 2024
Biotechnology
Novartis reports Phase III success for SMA gene therapy
30 December 2024
Biotechnology
How can CDMOs drive ADC success from lab to launch?
30 December 2024
Biotechnology
Daiichi Sankyo’s Datroway gains Japanese approval
30 December 2024

Company Spotlight

A clinical-stage immuno-oncology company from Switzerland.




More Features in Biotechnology

Rybrevant combo gains EU nod in first-line lung cancer
30 December 2024
Novartis reports Phase III success for SMA gene therapy
30 December 2024
How can CDMOs drive ADC success from lab to launch?
30 December 2024
Daiichi Sankyo’s Datroway gains Japanese approval
30 December 2024


Copyright © The Pharma Letter 2024   |   Headless Content Management with Blaze